FRANKLIN RESOURCES INC filings

This page lists the SEC filings reported by FRANKLIN RESOURCES INC.

SEC filings by FRANKLIN RESOURCES INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-06FRANKLIN RESOURCES INCApplied Therapeutics Inc.7,793,91210.0%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCBridge Investment Group Holdings Inc.1,550,9744.5%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCDXC Technology Co8,220,8964.2%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCEyePoint Pharmaceuticals, Inc.4,640,6519.5%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCGaliano Gold Inc.8,207,2623.6%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCHERON THERAPEUTICS, INC. /DE/6,404,7954.3%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCIntegra Resources Corp.6,248,1818.6%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCNerdy Inc.4,267,2184.1%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCONESPAWORLD HOLDINGS Ltd5,298,5445.3%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCPaymentus Holdings, Inc.2,189,57810.7%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCPLATINUM GROUP METALS LTD13,252,27912.9%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCSITIME Corp1,198,8415.3%EDGAR
SC 13G/A2024-02-06FRANKLIN RESOURCES INCVizsla Silver Corp.17,756,0008.5%EDGAR
SC 13G2024-02-06FRANKLIN RESOURCES INCAcumen Pharmaceuticals, Inc.3,358,8095.8%EDGAR
SC 13G2024-02-06FRANKLIN RESOURCES INCCullinan Oncology, Inc.3,281,2807.7%EDGAR
SC 13G2024-02-06FRANKLIN RESOURCES INCMARINUS PHARMACEUTICALS, INC.3,833,9557.0%EDGAR
SC 13G2024-02-06FRANKLIN RESOURCES INCOIL STATES INTERNATIONAL, INC3,464,9395.2%EDGAR
SC 13G2024-02-06FRANKLIN RESOURCES INCRevance Therapeutics, Inc.6,108,2776.8%EDGAR
SC 13G/A2024-01-29BlackRock Inc.FRANKLIN RESOURCES INC29,501,9866.0%EDGAR
SC 13G/A2024-01-25STATE STREET CORPFRANKLIN RESOURCES INC-4.4%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.